Article
A novel epidermal growth factor receptor-signaling platform and its targeted translation in pancreatic cancer
30 Aug 2013
Abstract excerpt
Epidermal growth factor (EGF)-induced EGFR tyrosine kinase receptor activation in cancer cell survival responses has become a strategic molecular-targeting clinical therapeutic intent, but the failures of these targeted approaches in the clinical setting demand alternate strategies. Here, we uncover a novel neuraminidase-1 (Neu1) and matrix metalloproteinase-9 (MMP-9) cross-talk in alliance with GPCR neuromedin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
